Beam Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BEAM and other ETFs, options, and stocks.

About BEAM

Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which includes access to base editing technologies and associated technologies that enhance the scope of base editing. 

CEO
John Evans
CEOJohn Evans
Employees
341
Employees341
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2017
Founded2017
Employees
341
Employees341

BEAM Key Statistics

Market cap
3.58B
Market cap3.58B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.01M
Average volume1.01M
High today
$51.28
High today$51.28
Low today
$48.54
Low today$48.54
Open price
$50.68
Open price$50.68
Volume
639.21K
Volume639.21K
52 Week high
$100.06
52 Week high$100.06
52 Week low
$27.77
52 Week low$27.77

Analyst ratings

62%

of 13 ratings
Buy
61.5%
Hold
38.5%
Sell
0%

BEAM Earnings

-$3.35
-$2.23
-$1.12
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 7, Pre-Market
ActualExpected Nov 7, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.